AUS
NZ
UK
CA
USA
IND
Healthcare
Avidity Biosciences Grants Stock Options and RSUs to New Chief Legal Officer
August 05, 2024 12:00 AM PDT| By Team Kalkine MediaHeadlines,Avidity Biosciences announced stock option and RSU grants to John B. Moriarty, Jr. as part of his hiring package.,The awards were granted under the 2022 Employment Inducement Incentive Award Plan in compliance with Nasdaq Listing Rule 5635(...
TransMedics Sees Stock Price Surge After Impressive Earnings Report
August 02, 2024 07:27 AM PDT| By Team Kalkine MediaHeadlnes,TransMedics reports a 118% revenue increase for Q2 2024, surpassing expectations.,The company raised its full-year 2024 revenue outlook, indicating significant growth.,Expansion of logistics services and plans for new clinical programs drive...
Is Merck a Strong Bet After Q2 Performance?
August 02, 2024 07:18 AM PDT| By Team Kalkine MediaHeadlines,Merck’s Q2 results exceeded revenue and earnings estimates.,Keytruda sales drove growth, but Gardasil faced shipment issues.,Stock is trading near estimated value, with an uncertain future outlook.,Merck,(NYSE:MRK),recently reported its Q2...
Pfizer’s Bold $43 Billion Move: Is It Paying Off?
August 02, 2024 12:00 AM PDT| By Team Kalkine MediaHeadlines,Pfizer's acquisition of Seagen aims to boost its oncology portfolio significantly.,Seagen’s products show promise in capturing market share and driving revenue growth.,The oncology drug market's expected expansion aligns with Pfizer’s long-...
Why is Inari Medical Making Headlines Today
July 31, 2024 06:06 AM PDT| By Team Kalkine MediaInari Medical (,NARI,), a company specializing in minimally invasive solutions for venous and vascular diseases, released its second-quarter financial results on July 30. The company achieved notable revenue growth but also faced significant increase...
Tenet Healthcare (NYSE:THC) Jumps 18 Spots on Barchart’s Top 100
July 31, 2024 04:30 AM PDT| By Team Kalkine MediaTenet Healthcare,(NYSE:THC),leaped 18 places in Barchart’s Top 100 list, now ranked 67th with a weighted alpha of 119.97, surpassing its impressive 106% return over the last year. When the weighted alpha exceeds the 52-week return, it suggests that t...
ProAssurance (PRA) Soars 12.6%: What's Next?
July 31, 2024 12:00 AM PDT| By Team Kalkine MediaProAssurance (PRA) shares surged 12.6% in the last trading session, ending at $13.16. This increase was supported by significant trading volume, surpassing the usual activity. In contrast, the stock had previously declined by 4.2% over the past month...
Teva Pharmaceutical Industries (NYSE:TEVA) Q2 2024 Earnings Overview
July 31, 2024 12:00 AM PDT| By Team Kalkine MediaThe Motley Fool Stock Advisor analyst team has recently highlighted their top 10 stock selections, notably excluding Teva Pharmaceutical Industries,(NYSE:TEVA),.The chosen stocks are anticipated to yield significant returns in the future.,Reflecting...
SCOR Q2 Loss Amid Rising Revenues; L&H CEO to Depart
July 30, 2024 05:10 AM PDT| By Team Kalkine MediaHeadlines:,SCOR Reports Q2 Loss Amid Mixed Revenue Growth,P&C Insurance Revenue Sees Notable Increase; L&H Revenue Marginally Declines,L&H CEO Frieder Knupling Steps Down; Thierry Leger Assumes Role,SCOR SE (OTC:SZCRF), a leading French reinsurance p...
Calquence-Venetoclax Combo Shows Promise; Impact on Healthcare Stocks
July 29, 2024 05:19 AM PDT| By Team Kalkine MediaHeadlines:,Amplify Trial Results Show Significant Improvement with Calquence Combination,Trend Favoring Calquence in Overall Survival Observed, Awaiting Further Data,Chronic Lymphocytic Leukemia Cases Expected to Rise Globally,AstraZeneca(NASDAQ:AZN)...
GSK’s Arexvy RSV Vaccine Gains CHMP Approval for Ages 50-59
July 29, 2024 05:14 AM PDT| By Team Kalkine MediaHeadlines:,GSK’s Arexvy RSV Vaccine Receives Positive CHMP Opinion for Adults Aged 50-59 at Higher Risk,Expansion of Arexvy Approval Could Include Adults Aged 50-59 by September 2024,GSK’s RSV Vaccine Trials Progress in Multiple Regions, Including th...
Merck's Q2 2024 Earnings Preview: Key Trends and Future Prospects
July 29, 2024 04:57 AM PDT| By Team Kalkine MediaHeadlines:,Q2 2024 Revenue and Earnings Expectations,Stock Performance and Market Trends Analysis,Valuation Insights and Future Outlook,Merck (NYSE:MRK) is scheduled to unveil its Q2 2024 financial results on Tuesday, July 30. Anticipations are set f...
Pfizer's Q2 2024 Outlook: Revenue Projections and Market Performance
July 29, 2024 04:52 AM PDT| By Team Kalkine MediaHeadlines:,Pfizer's Q2 Report and Revenue Expectations,Historical Stock Performance and Market Trends,Valuation Insights and Future Predictions,Pfizer (NYSE:PFE) is set to disclose its Q2 2024 financial results on Tuesday, July 30. Analysts anticipat...
Bausch Health Addresses Bankruptcy Speculation, Affirms No Plans for Filing
July 25, 2024 10:27 AM PDT| By Team Kalkine MediaHeadlines:,Bausch Health responds to bankruptcy,rumors,, clarifying that it is not contemplating bankruptcy.,The company emphasizes its commitment to,maintaining,financial stability and addressing market concerns.,Bausch Health aims to reassure stake...
HCA Healthcare Stock Soars as Company Exceeds Expectations and Upgrades Revenue Forecast
July 24, 2024 12:00 AM PDT| By Team Kalkine MediaSummary:,- HCA Healthcare's stock increased by over 5% on Tuesday.,- The company's performance exceeded expectations.,- HCA Healthcare raised its full-year forecast.,- Net income rose to $1.46 billion, with earnings per share reaching $5.53.,- Sales...
Novartis (SWX: NOVN) Reports Robust Q2 Growth, Raises FY 2024 Guidance
July 18, 2024 11:07 PM PDT| By Team Kalkine MediaNovartis (SWX: NOVN) has delivered strong financial results in the second quarter of 2024, leading to a raised full-year bottom-line guidance. The company achieved notable increases in net sales and core operating income, highlighting the success of...
GE HealthCare (Nasdaq: GEHC) Expands AI Capabilities with Intelligent Ultrasound Acquisition
July 18, 2024 01:47 AM PDT| By Team Kalkine MediaGE Healthcare (Nasdaq: GEHC) has announced a strategic acquisition aimed at bolstering its capabilities in clinical artificial intelligence (AI) software. The agreement involves acquiring Intelligent Ultrasound Group PLC’s (Intelligent Ultrasound) AI...
UnitedHealth Group (NYSE: UNH) Reports Strong Second Quarter 2024 Results Amid Growth and Challenges
July 16, 2024 10:05 PM PDT| By Team Kalkine MediaUnitedHealth Group (,NYSE: UNH,) has announced its second quarter 2024 financial results, demonstrating robust performance driven by significant growth across its Optum and UnitedHealthcare segments. The company reported revenues totalling $98.9 bill...
Mainz Biomed N.V. (NASDAQ: MYNZ), Pursues Breakthrough Device Designation for Next-Generation Colorectal Cancer Test
July 09, 2024 02:01 AM PDT| By Team Kalkine MediaMainz Biomed N.V. (,NASDAQ: MYNZ,), a frontrunner in molecular genetics diagnostics with a focus on early cancer detection, has reached a pivotal milestone by submitting an application to the U.S. Food and Drug Administration (FDA) for Breakthrough D...
GSK’s (LSE/NYSE: GSK) Omjjara Approved in Japan for Myelofibrosis Treatment
June 27, 2024 02:24 AM PDT| By Team Kalkine MediaGSK plc (LSE/,NYSE: GSK,) has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Omjjara (momelotinib) for the treatment of myelofibrosis. Omjjara is a once-daily, oral inhibitor of JAK1/JAK2 and activin A receptor type...
